Piper Sandler Has Lowered Expectations for Akoya Biosciences (NASDAQ:AKYA) Stock Price
Akoya Biosciences (NASDAQ:AKYA – Get Free Report) had its target price decreased by investment analysts at Piper Sandler from $2.40 to $1.65 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 38.66% from the stock’s previous close. […]
Akoya Biosciences (NASDAQ:AKYA – Get Free Report) had its target price decreased by investment analysts at Piper Sandler from $2.40 to $1.65 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 38.66% from the stock’s previous close. […]
